Drugmaker CEOs Remain Skeptical of Silicon Valley's Claims That AI Will Cure Disease

Technology companies in Silicon Valley have been promoting the idea that artificial intelligence will soon lead to cures for a wide range of diseases. Executives at pharmaceutical companies, however, are reportedly unconvinced by these predictions. The Wall Street Journal's report highlights the gap between tech industry optimism and the more cautious view held by the drug industry's leadership. The article, shared on Hacker News, drew modest engagement from readers discussing the topic. The available source material provides only the headline and link, so the specific reasons behind the drugmakers' skepticism are not detailed here.